Altamira Therapeutics prices up to $12M public offering (NASDAQ:CYTO)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 17 2024
0mins
Source: SeekingAlpha
Public Offering Announcement: Altamira Therapeutics has priced a public offering of 5.56 million common shares, along with Series A-1 and A-2 common warrants, at a price of $0.72 per share.
Financial Implications: The offering is expected to generate significant gross proceeds for the company.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
